Nifty
:
26186.45
Sensex
:
85712.37
152.70 (0.59%)
447.05 (0.52%)
Nifty
Sensex
:
:
26186.45
85712.37
152.70 (0.59%)
447.05 (0.52%)

Sandu Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :
51/99

BSE: 524703 | NSE: Not Listed

NSE BSE
39.50
05-Dec-2025
  • Open
  • High
  • Low
  • Previous Close
  •  40
  •  40
  •  39.03
  •  40.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2052
  •  80940
  •  40
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 38.16
  • 23.41
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 35.51
  • 2.03%
  • 1.13

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 42.91%
  • 18.15%
  • 36.77%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 2.17%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.04
  • 2.72
  • 0.93

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.39
  • 5.02
  • 2.08

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.12
  • 7.30
  • 0.65

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 32.63
  • 36.09
  • 37.15

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.57
  • 1.70
  • 1.67

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.41
  • 17.16
  • 18.71

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
0.00
17.04
-100.00%
14.07
15.60
-9.81%
0.00
17.43
-100.00%
17.71
16.61
6.62%
Expenses
0.00
16.64
-100.00%
13.62
14.99
-9.14%
0.00
16.92
-100.00%
16.79
15.78
6.40%
EBITDA
0.00
0.41
-100.00%
0.45
0.60
-25.00%
0.00
0.51
-100.00%
0.91
0.82
10.98%
EBIDTM
0.00%
2.38%
3.18%
3.87%
0.00%
2.92%
5.14%
4.97%
Other Income
0.00
0.05
-100.00%
0.07
0.31
-77.42%
0.00
0.03
-100.00%
0.03
0.09
-66.67%
Interest
0.00
0.02
-100.00%
0.03
0.01
200.00%
0.00
0.02
-100.00%
0.03
0.02
50.00%
Depreciation
0.00
0.16
-100.00%
0.15
0.19
-21.05%
0.00
0.14
-100.00%
0.17
0.13
30.77%
PBT
0.00
0.27
-100.00%
0.34
0.72
-52.78%
0.00
0.38
-100.00%
0.74
0.76
-2.63%
Tax
0.00
0.11
-100.00%
0.02
0.12
-83.33%
0.00
0.17
-100.00%
0.24
0.21
14.29%
PAT
0.00
0.17
-100.00%
0.33
0.60
-45.00%
0.00
0.21
-100.00%
0.50
0.55
-9.09%
PATM
0.00%
0.97%
2.32%
3.82%
0.00%
1.18%
2.80%
3.31%
EPS
0.00
0.17
-100.00%
0.34
0.62
-45.16%
0.00
0.21
-100.00%
0.51
0.57
-10.53%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Net Sales
-
67.19
67.28
65.35
Net Sales Growth
-
-0.13%
2.95%
 
Cost Of Goods Sold
-
32.10
32.57
31.19
Gross Profit
-
35.09
34.71
34.16
GP Margin
-
52.23%
51.59%
52.27%
Total Expenditure
-
64.43
64.98
62.86
Power & Fuel Cost
-
0.41
0.41
0.39
% Of Sales
-
0.61%
0.61%
0.60%
Employee Cost
-
10.92
10.07
11.10
% Of Sales
-
16.25%
14.97%
16.99%
Manufacturing Exp.
-
3.54
3.42
3.32
% Of Sales
-
5.27%
5.08%
5.08%
General & Admin Exp.
-
6.18
6.46
6.91
% Of Sales
-
9.20%
9.60%
10.57%
Selling & Distn. Exp.
-
11.03
11.71
9.71
% Of Sales
-
16.42%
17.40%
14.86%
Miscellaneous Exp.
-
0.24
0.34
0.25
% Of Sales
-
0.36%
0.51%
0.38%
EBITDA
-
2.76
2.30
2.49
EBITDA Margin
-
4.11%
3.42%
3.81%
Other Income
-
0.17
0.42
0.33
Interest
-
0.10
0.06
0.08
Depreciation
-
0.67
0.58
0.52
PBT
-
2.16
2.07
2.22
Tax
-
0.61
0.61
0.70
Tax Rate
-
28.24%
29.47%
31.53%
PAT
-
1.55
1.46
1.52
PAT before Minority Interest
-
1.55
1.46
1.52
Minority Interest
-
0.00
0.00
0.00
PAT Margin
-
2.31%
2.17%
2.33%
PAT Growth
-
6.16%
-3.95%
 
EPS
-
1.60
1.51
1.57

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Shareholder's Funds
42.02
40.59
39.24
Share Capital
9.66
9.66
9.66
Total Reserves
32.36
30.93
29.58
Non-Current Liabilities
1.62
1.18
1.04
Secured Loans
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
Current Liabilities
12.09
10.64
13.88
Trade Payables
4.49
4.20
8.40
Other Current Liabilities
2.22
1.47
1.41
Short Term Borrowings
0.00
0.00
0.00
Short Term Provisions
5.38
4.98
4.08
Total Liabilities
55.73
52.41
54.16
Net Block
18.15
17.88
16.62
Gross Block
30.29
29.35
27.51
Accumulated Depreciation
12.14
11.47
10.89
Non Current Assets
29.42
30.11
28.62
Capital Work in Progress
0.00
0.00
0.42
Non Current Investment
11.22
10.42
9.65
Long Term Loans & Adv.
0.00
0.00
0.00
Other Non Current Assets
0.05
1.82
1.94
Current Assets
26.30
22.30
25.55
Current Investments
0.00
0.00
0.00
Inventories
14.15
12.25
14.33
Sundry Debtors
4.76
4.87
4.79
Cash & Bank
2.65
1.21
2.30
Other Current Assets
4.74
0.18
0.22
Short Term Loans & Adv.
4.52
3.80
3.92
Net Current Assets
14.21
11.66
11.66
Total Assets
55.72
52.41
54.17

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Cash From Operating Activity
0.95
0.76
0.22
PBT
2.16
2.07
2.22
Adjustment
0.70
0.41
0.48
Changes in Working Capital
-1.32
-1.22
-1.77
Cash after chg. in Working capital
1.53
1.26
0.92
Interest Paid
0.00
0.00
0.00
Tax Paid
-0.58
-0.50
-0.70
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-0.19
-1.31
0.54
Net Fixed Assets
-0.94
-1.42
Net Investments
-0.79
-0.77
Others
1.54
0.88
Cash from Financing Activity
-0.46
-0.72
0.58
Net Cash Inflow / Outflow
0.30
-1.27
1.34
Opening Cash & Equivalents
1.00
2.28
0.94
Closing Cash & Equivalent
1.30
1.00
2.28

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Book Value (Rs.)
34.63
33.01
40.62
ROA
2.87%
2.74%
2.81%
ROE
4.75%
4.11%
3.87%
ROCE
6.92%
6.01%
5.85%
Fixed Asset Turnover
2.25
2.37
2.38
Receivable days
26.14
26.20
26.77
Inventory Days
71.70
72.09
80.01
Payable days
49.36
70.56
98.27
Cash Conversion Cycle
48.49
27.73
8.51
Total Debt/Equity
0.00
0.00
0.00
Interest Cover
21.90
33.85
28.85

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.